CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis

Yan-ming Dong, Guo-qiang Bao Department of General Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi’an, Shaanxi Province, People’s Republic of ChinaCorrespondence: Guo-qiang Bao, Department of General Surgery, The Second Affiliated Hospital of Air Force Medical University,...

Full description

Saved in:
Bibliographic Details
Main Authors: Dong YM, Bao GQ
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Online Access:https://www.dovepress.com/cd27-as-a-diagnostic-biomarker-and-its-role-in-immune-heterogeneity-an-peer-reviewed-fulltext-article-PGPM
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846118505151201280
author Dong YM
Bao GQ
author_facet Dong YM
Bao GQ
author_sort Dong YM
collection DOAJ
description Yan-ming Dong, Guo-qiang Bao Department of General Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi’an, Shaanxi Province, People’s Republic of ChinaCorrespondence: Guo-qiang Bao, Department of General Surgery, The Second Affiliated Hospital of Air Force Medical University, No. 356 of Xinsi Road, Baqiao District, Xi’an, Shaanxi Province, People’s Republic of China, Tel +86 13891430409, Email baoguoqiang_ln@163.comObjective: To identify key genes and potential molecular mechanisms associated with Hashimoto’s thyroiditis (HT) to provide new insights for the development of diagnostic and therapeutic targets for this disease.Methods: Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were conducted to identify the differentially expressed genes (DEGs) associated with HT. A protein-protein interaction (PPI) network was used to obtain hub genes, with CD27 emerging as the key gene in HT. Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, Gene Set Enrichment Analysis (GSEA), and HT-infiltrating immune cell components as well as functions were performed to further investigate the role and potential mechanism of CD27 in cohorts with high and low expression of CD27.Results: CD27 was found to be upregulated in HT tissues and showed considerable clinical utility in HT. The CD27 of the high-expression cohort exhibited a higher enrichment in immune-related biological processes than the low-expression group. Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) analysis revealed that several activated HT-infiltrating immune cells were strongly associated with CD27, suggesting that CD27 has the potential to be a marker for the immune state in HT.Conclusion: In our study, CD27 was found to contribute to predicting clinical outcomes in patients with HT, including disease status and response to immunotherapy. CD27 is a promising biomarker for HT microenvironment remodeling, offering insights into new therapeutic approaches to improve treatment of HT.Keywords: CD27, diagnosis, drug response, Hashimoto’s thyroiditis, immune heterogeneity
format Article
id doaj-art-2c99cdff1a99411dac9e5a242716aaa4
institution Kabale University
issn 1178-7066
language English
publishDate 2024-12-01
publisher Dove Medical Press
record_format Article
series Pharmacogenomics and Personalized Medicine
spelling doaj-art-2c99cdff1a99411dac9e5a242716aaa42024-12-17T17:00:25ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662024-12-01Volume 1753555098431CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s ThyroiditisDong YMBao GQYan-ming Dong, Guo-qiang Bao Department of General Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi’an, Shaanxi Province, People’s Republic of ChinaCorrespondence: Guo-qiang Bao, Department of General Surgery, The Second Affiliated Hospital of Air Force Medical University, No. 356 of Xinsi Road, Baqiao District, Xi’an, Shaanxi Province, People’s Republic of China, Tel +86 13891430409, Email baoguoqiang_ln@163.comObjective: To identify key genes and potential molecular mechanisms associated with Hashimoto’s thyroiditis (HT) to provide new insights for the development of diagnostic and therapeutic targets for this disease.Methods: Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were conducted to identify the differentially expressed genes (DEGs) associated with HT. A protein-protein interaction (PPI) network was used to obtain hub genes, with CD27 emerging as the key gene in HT. Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, Gene Set Enrichment Analysis (GSEA), and HT-infiltrating immune cell components as well as functions were performed to further investigate the role and potential mechanism of CD27 in cohorts with high and low expression of CD27.Results: CD27 was found to be upregulated in HT tissues and showed considerable clinical utility in HT. The CD27 of the high-expression cohort exhibited a higher enrichment in immune-related biological processes than the low-expression group. Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) analysis revealed that several activated HT-infiltrating immune cells were strongly associated with CD27, suggesting that CD27 has the potential to be a marker for the immune state in HT.Conclusion: In our study, CD27 was found to contribute to predicting clinical outcomes in patients with HT, including disease status and response to immunotherapy. CD27 is a promising biomarker for HT microenvironment remodeling, offering insights into new therapeutic approaches to improve treatment of HT.Keywords: CD27, diagnosis, drug response, Hashimoto’s thyroiditis, immune heterogeneityhttps://www.dovepress.com/cd27-as-a-diagnostic-biomarker-and-its-role-in-immune-heterogeneity-an-peer-reviewed-fulltext-article-PGPMcd27diagnosisdrug responsehashimoto's thyroiditisimmune heterogeneity.
spellingShingle Dong YM
Bao GQ
CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
Pharmacogenomics and Personalized Medicine
cd27
diagnosis
drug response
hashimoto's thyroiditis
immune heterogeneity.
title CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
title_full CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
title_fullStr CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
title_full_unstemmed CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
title_short CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
title_sort cd27 as a diagnostic biomarker and its role in immune heterogeneity and predicting clinical drug responses in hashimoto rsquo s thyroiditis
topic cd27
diagnosis
drug response
hashimoto's thyroiditis
immune heterogeneity.
url https://www.dovepress.com/cd27-as-a-diagnostic-biomarker-and-its-role-in-immune-heterogeneity-an-peer-reviewed-fulltext-article-PGPM
work_keys_str_mv AT dongym cd27asadiagnosticbiomarkeranditsroleinimmuneheterogeneityandpredictingclinicaldrugresponsesinhashimotorsquosthyroiditis
AT baogq cd27asadiagnosticbiomarkeranditsroleinimmuneheterogeneityandpredictingclinicaldrugresponsesinhashimotorsquosthyroiditis